Audible Premium Plus. $0.99/month for the first 3-months. Get this deal! $14.95 a month after 3 months. Cancel anytime. Offers ends July 31, 2024 11:59pm

What's Wrong With The UK Extended Access Program?
Jan 11 2024
Length: 19 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

What's Wrong With The UK Extended Access Program?

Listen for free

View show details

Summary
The extended access scheme allows patients to have early access to drugs which are not approved on the market but have shown potential in clinical trials. In the UK for the last 10 years were treated over 1,200 patients while in the USA just in 2022 were treated 2,417 patients. Why is that difference? You can learn more from this episode and what could be done to improve access to medications to more patients in the UK.

Show more Show less

Show more Show less

What listeners say about What's Wrong With The UK Extended Access Program?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon